Genomic organization and transcriptional regulation of human Apo2/TRAIL gene

被引:67
作者
Gong, B
Almasan, A
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Lerner Res Inst, Dept Radiat Oncol, Cleveland, OH 44195 USA
关键词
Apo2L; Apo2L promoter; apoptosis; interferon; TNF; TRAIL; transcription;
D O I
10.1006/bbrc.2000.3872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apo2L, or TRAIL, is a type II integral membrane protein belonging to the TNF family which induces apoptotic cell death in a variety of human tumor cells. Apo2L is expressed in many tissues, suggesting that it is nontoxic to normal cells. We found that Apo2L mRNA was induced by interferon (IFN)-alpha and -beta, but not -gamma, in Jurkat cells. To gain a better understanding of the molecular mechanisms that regulate expression of Apo2L, we have characterized the organization of the human Apo2L gene and its promoter region. The Apo2L gene spans approximately 20 kb and is composed of five exons. The 1.2-kb Apo2L promoter region upstream of the translation initiation codon was cloned, its transcription start site defined, and several putative transcription factor binding sites identified. Luciferase reporter constructs were transfected into Jurkat cells and shown to be induced by IFNs. Deletion analysis indicates that the Apo2L promoter region between nucleotides 126 and 33 upstream of the transcriptional start site controls the expression of the Apo2L gene following IFN-beta treatment. (C) 2000 Academic Press.
引用
收藏
页码:747 / 752
页数:6
相关论文
共 20 条
[1]   CCAAT/enhancer-binding proteins - A role in regulation of human involucrin promoter response to phorbol ester [J].
Agarwal, C ;
Efimova, T ;
Welter, JF ;
Crish, JF ;
Eckert, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6190-6194
[2]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[3]   An Sp1 binding site involves the transcription of the Fas ligand gene induced by PMA and ionomycin in Jurkat cells [J].
Chou, CF ;
Peng, HW ;
Wang, CY ;
Yang, YT ;
Han, SH .
JOURNAL OF BIOMEDICAL SCIENCE, 2000, 7 (02) :136-143
[4]  
Gong BD, 2000, CANCER RES, V60, P5754
[5]  
Gong BD, 1999, CELL GROWTH DIFFER, V10, P491
[6]   Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL [J].
Griffith, TS ;
Wiley, SR ;
Kubin, MZ ;
Sedger, LM ;
Maliszewski, CR ;
Fanger, NA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1343-1353
[7]   A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription [J].
Hafner, M ;
Zimmermann, K ;
Pottgiesser, J ;
Krieg, T ;
Nischt, R .
MATRIX BIOLOGY, 1995, 14 (09) :733-741
[8]   Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL [J].
Heinemeyer, T ;
Wingender, E ;
Reuter, I ;
Hermjakob, H ;
Kel, AE ;
Kel, OV ;
Ignatieva, EV ;
Ananko, EA ;
Podkolodnaya, OA ;
Kolpakov, FA ;
Podkolodny, NL ;
Kolchanov, NA .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :362-367
[9]   Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand [J].
Jo, M ;
Kim, TH ;
Seol, DW ;
Esplen, JE ;
Dorko, K ;
Billiar, TR ;
Strom, SC .
NATURE MEDICINE, 2000, 6 (05) :564-567
[10]   Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type IIFNs [J].
Kayagaki, N ;
Yamaguchi, N ;
Nakayama, M ;
Eto, H ;
Okumura, K ;
Yagita, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (09) :1451-1460